{"id":"https://openalex.org/W1078286986","doi":"https://doi.org/10.1007/s40265-013-0015-5","title":"Next-Generation Integrase Inhibitors: Where to After Raltegravir?","display_name":"Next-Generation Integrase Inhibitors: Where to After Raltegravir?","alternate_titles":[],"publication_year":2013,"publication_date":"2013-02-15","ids":{"openalex":"https://openalex.org/W1078286986","doi":"https://doi.org/10.1007/s40265-013-0015-5","mag":"1078286986","pmid":"https://pubmed.ncbi.nlm.nih.gov/23413196"},"language":"en","primary_location":{"id":"doi:10.1007/s40265-013-0015-5","doi":"https://doi.org/10.1007/s40265-013-0015-5","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s40265-013-0015-5","pdf_url":null,"source":{"id":"https://openalex.org/S4436492","display_name":"Drugs","issn_l":"0012-6667","issn":["0012-6667","1179-1950"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1078286986"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111789703","display_name":"Sharon L. Karmon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I157122930","display_name":"Aaron Diamond AIDS Research Center","ror":"https://ror.org/04jdq2t93","country_code":"US","type":"facility","lineage":["https://openalex.org/I157122930"]},{"id":"https://openalex.org/I83399316","display_name":"Rockefeller University","ror":"https://ror.org/0420db125","country_code":"US","type":"education","lineage":["https://openalex.org/I83399316"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sharon L. Karmon","raw_affiliation_strings":["Aaron Diamond AIDS Research Center, 7th Floor, 455 First Avenue, New York, NY 10016, USA","Aaron Diamond AIDS Research Center, New York, USA","Rockefeller University, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aaron Diamond AIDS Research Center, 7th Floor, 455 First Avenue, New York, NY 10016, USA","institution_ids":["https://openalex.org/I157122930"]},{"raw_affiliation_string":"Aaron Diamond AIDS Research Center, New York, USA","institution_ids":["https://openalex.org/I157122930"]},{"raw_affiliation_string":"Rockefeller University, New York, USA","institution_ids":["https://openalex.org/I83399316"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065883600","display_name":"Martin H. Markowitz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I157122930","display_name":"Aaron Diamond AIDS Research Center","ror":"https://ror.org/04jdq2t93","country_code":"US","type":"facility","lineage":["https://openalex.org/I157122930"]},{"id":"https://openalex.org/I83399316","display_name":"Rockefeller University","ror":"https://ror.org/0420db125","country_code":"US","type":"education","lineage":["https://openalex.org/I83399316"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Martin Markowitz","raw_affiliation_strings":["Aaron Diamond AIDS Research Center, 7th Floor, 455 First Avenue, New York, NY, 10016, USA","Rockefeller University, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aaron Diamond AIDS Research Center, 7th Floor, 455 First Avenue, New York, NY, 10016, USA","institution_ids":["https://openalex.org/I157122930"]},{"raw_affiliation_string":"Rockefeller University, New York, NY, USA","institution_ids":["https://openalex.org/I83399316"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5065883600"],"corresponding_institution_ids":["https://openalex.org/I157122930","https://openalex.org/I83399316"],"apc_list":{"value":5990,"currency":"USD","value_usd":5990},"apc_paid":null,"fwci":1.3213,"has_fulltext":false,"cited_by_count":59,"citation_normalized_percentile":{"value":0.77155444,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"73","issue":"3","first_page":"213","last_page":"228"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/integrase-inhibitors","display_name":"integrase inhibitors","score":0.8650000095367432},{"id":"https://openalex.org/keywords/hiv-1-infection","display_name":"HIV-1 infection","score":0.9039999842643738},{"id":"https://openalex.org/keywords/raltegravir","display_name":"raltegravir","score":0.9779999852180481},{"id":"https://openalex.org/keywords/elvitegravir","display_name":"elvitegravir","score":0.9629999995231628},{"id":"https://openalex.org/keywords/dolutegravir","display_name":"dolutegravir","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ledgf-p75","display_name":"LEDGF/p75","score":0.7649999856948853},{"id":"https://openalex.org/keywords/cross-resistance","display_name":"cross-resistance","score":0.722000002861023},{"id":"https://openalex.org/keywords/antiretroviral-drug-resistance","display_name":"antiretroviral resistance","score":0.8240000009536743},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.9430000185966492},{"id":"https://openalex.org/keywords/integrase-strand-transfer-inhibitors","display_name":"integrase strand transfer inhibitors","score":0.8220000267028809}],"concepts":[{"id":"https://openalex.org/C2780404665","wikidata":"https://www.wikidata.org/wiki/Q421552","display_name":"Raltegravir","level":5,"score":0.9281564950942993},{"id":"https://openalex.org/C2777068322","wikidata":"https://www.wikidata.org/wiki/Q2740966","display_name":"Elvitegravir","level":5,"score":0.9245362281799316},{"id":"https://openalex.org/C2777302000","wikidata":"https://www.wikidata.org/wiki/Q412251","display_name":"Integrase inhibitor","level":5,"score":0.7867381572723389},{"id":"https://openalex.org/C2779502633","wikidata":"https://www.wikidata.org/wiki/Q937224","display_name":"Dolutegravir","level":5,"score":0.7682496309280396},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.646033763885498},{"id":"https://openalex.org/C14430832","wikidata":"https://www.wikidata.org/wiki/Q412550","display_name":"Integrase","level":3,"score":0.6414563655853271},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6373226642608643},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5780388116836548},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.46413299441337585},{"id":"https://openalex.org/C2779298103","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Ritonavir","level":5,"score":0.437716007232666},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4272095561027527},{"id":"https://openalex.org/C2780524789","wikidata":"https://www.wikidata.org/wiki/Q5138908","display_name":"Cobicistat","level":5,"score":0.4241045117378235},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2026425302028656},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.16311568021774292},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.1474694311618805},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.12078505754470825},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.09333965182304382}],"mesh":[{"descriptor_ui":"D000068898","descriptor_name":"Raltegravir Potassium","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000099226","descriptor_name":"Dolutegravir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006575","descriptor_name":"Heterocyclic Compounds, 3-Ring","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D006575","descriptor_name":"Heterocyclic Compounds, 3-Ring","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010078","descriptor_name":"Oxazines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011760","descriptor_name":"Pyrrolidinones","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011760","descriptor_name":"Pyrrolidinones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019428","descriptor_name":"HIV Integrase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019428","descriptor_name":"HIV Integrase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s40265-013-0015-5","doi":"https://doi.org/10.1007/s40265-013-0015-5","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s40265-013-0015-5","pdf_url":null,"source":{"id":"https://openalex.org/S4436492","display_name":"Drugs","issn_l":"0012-6667","issn":["0012-6667","1179-1950"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs","raw_type":"journal-article"},{"id":"pmid:23413196","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23413196","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":72,"referenced_works":["https://openalex.org/W302056891","https://openalex.org/W1846381171","https://openalex.org/W1967390610","https://openalex.org/W1973261539","https://openalex.org/W1983837630","https://openalex.org/W1983855045","https://openalex.org/W1988062692","https://openalex.org/W1988570950","https://openalex.org/W1990069515","https://openalex.org/W1990533335","https://openalex.org/W1993363443","https://openalex.org/W2007831756","https://openalex.org/W2008603042","https://openalex.org/W2011532461","https://openalex.org/W2012064675","https://openalex.org/W2016087474","https://openalex.org/W2020474856","https://openalex.org/W2021395278","https://openalex.org/W2022650067","https://openalex.org/W2025444624","https://openalex.org/W2028179886","https://openalex.org/W2030854058","https://openalex.org/W2032800042","https://openalex.org/W2036917641","https://openalex.org/W2052287045","https://openalex.org/W2053125329","https://openalex.org/W2075052852","https://openalex.org/W2075531822","https://openalex.org/W2077998490","https://openalex.org/W2078270157","https://openalex.org/W2078738195","https://openalex.org/W2078975498","https://openalex.org/W2087400133","https://openalex.org/W2088739874","https://openalex.org/W2090070116","https://openalex.org/W2092018069","https://openalex.org/W2095361185","https://openalex.org/W2098185748","https://openalex.org/W2099475302","https://openalex.org/W2104247925","https://openalex.org/W2104937944","https://openalex.org/W2106494657","https://openalex.org/W2108911473","https://openalex.org/W2109360985","https://openalex.org/W2112068078","https://openalex.org/W2113818541","https://openalex.org/W2114137926","https://openalex.org/W2123055341","https://openalex.org/W2125095669","https://openalex.org/W2133362267","https://openalex.org/W2135417699","https://openalex.org/W2139876724","https://openalex.org/W2140123055","https://openalex.org/W2141779363","https://openalex.org/W2144255757","https://openalex.org/W2145467751","https://openalex.org/W2147210767","https://openalex.org/W2150504993","https://openalex.org/W2151050670","https://openalex.org/W2152880150","https://openalex.org/W2154190260","https://openalex.org/W2154498922","https://openalex.org/W2157887699","https://openalex.org/W2158159244","https://openalex.org/W2159328065","https://openalex.org/W2161015308","https://openalex.org/W2161993838","https://openalex.org/W2187620446","https://openalex.org/W2189019003","https://openalex.org/W2323279270","https://openalex.org/W2523753142","https://openalex.org/W6885080515"],"related_works":["https://openalex.org/W1790877993","https://openalex.org/W2187981991","https://openalex.org/W2099607690","https://openalex.org/W2125095669","https://openalex.org/W2106095665","https://openalex.org/W2064131094","https://openalex.org/W3155554351","https://openalex.org/W2017402153","https://openalex.org/W2126563844","https://openalex.org/W2086617757"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1078286986","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":14},{"year":2013,"cited_by_count":8}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
